iNKTs and NKs inhibit tumor-associated macrophages (TAMs) and myeloid derived suppressor cells (MDSCs), kill cancer stem cells (CSCs), and tumor cells that have downregulated their MHC antigens, and robustly secrete cytokines to recruit additional immune effectors. Here, HLA-C is linked to neoplasm.